Regeneron Pharmaceuticals (REGN) Securities Class Action Hagens Berman Highlights Lawsuit Targeting Regeneron Pharmaceuticals (REGN) Over Alleged Misleading Statements SAN FRANCISCO, Sept. 12, 2026 (GLOBE NEWSWIRE) — Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has…

Read More

Editor' Pick

Canada News

Lifestyle

Tech & Innovation

Latest News